Method for Rapid Accurate Dispensing, Visualization and Analysis of Single Cells
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 62/118,965, filed Feb 20, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,641,772 | Method for Rapid Accurate Dispensing, Visualization and Analysis of Single Cells In force · High confidence UsedRemaining | Takara Bio USA, Inc. | In force | High confidence | ||
| US 11,125,752 | Method for Rapid Accurate Dispensing, Visualization and Analysis of Single Cells In force · High confidence | Takara Bio USA, Inc. | In force | High confidence | ||
| US 12,613,244 | Method for Rapid Accurate Dispensing, Visualization and Analysis of Single Cells In force · Low confidence | Takara Bio USA, Inc. | In force | Low confidence | ||
| Application 19/578,063 | Method for Rapid Accurate Dispensing, Visualization and Analysis of Single Cells Pending Not granted | Takara Bio USA, Inc. | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Takara Bio Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.